Technology ❯Biotechnology ❯Vaccine Technology

mRNA Technology

Vaccine Development Biontech Innovations Production Flexibility Rapid Vaccine Development

U.S. Cancels Moderna’s $600 Million Bird Flu Vaccine Contract

Health experts warn that removing support for an mRNA H5N1 vaccine delays rapid response capabilities against a potentially deadly pandemic threat.

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

WHO Launches Initiative to Develop mRNA Vaccines for H5N1 Bird Flu